The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Molecular mechanisms regulating glucocorticoid sensitivity and resistance
Open accessAbstract
Glucocorticoid receptor agonists are mainstays in the treatment of various malignancies of hematological origin. Glucocorticoids are included in therapeutic regimens for their ability to stimulate intracellular signal transduction cascades that culminate in alterations in the rate of transcription of genes involved in cell cycle progression and programmed cell death. Unfortunately, subpopulations of patients undergoing systemic glucocorticoid therapy for these diseases are or become insensitive to glucocorticoid-induced cell death, a phenomenon recognized as glucocorticoid resistance. Multiple factors contributing to glucocorticoid resistance have been identified. Here we summarize several of these mechanisms and describe the processes involved in generating a host of glucocorticoid receptor isoforms from one gene. The potential role of glucocorticoid receptor isoforms in determining cellular responsiveness to glucocorticoids is emphasized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Self-citationYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
A unified nomenclature system for the nuclear receptor superfamily
(1999) · Cell · doi:10.1016/s0092-8674(00)80726-6 · Cited by 1,208
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Functional interactions between Stat5 and the glucocorticoid receptor
Stöcklin, E., Wissler, M., Gouilleux, F., & Groner, B. (1996) · Nature · doi:10.1038/383726a0 · Cited by 675 · cited 3×
“, 1990), and signal transducers and activators of transcription (STAT) (Stocklin et al., 1996), and modulates their action at target genes.”
BackgroundGlucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Lu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455
Self-citationA New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427 · cited 4×
“[PubMed: 15017388] Rivers C, Levy A, Hancock J, Lightman S, Norman M. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing.”
BackgroundInfluentialWallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394
Self-citationvan Rossum, E. F. C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.333 · Cited by 381
The Hsp90‐binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo
Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung‐Flynn, J., Prapapanich, V., Ratajczak, T., Gaber, R., Picard, D., & Smith, D. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg108 · Cited by 353 · cited 1×
“The relative levels of FKBP51 and FKBP52 have been shown to be important determinants of cellular sensitivity to glucocorticoids in various systems (Reynolds et al., 1999; Denny et al., 2000; Scammell et al., 2001; Scammell et al., 2002; Riggs et al., 2003).”
BackgroundCroxtall, J. D., Choudhury, Q., & Flower, R. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703272 · Cited by 332 · cited 1×
“Croxtall et al. showed that glucocorticoids stimulate the release of Src kinase from GR heterocomplexes, resulting in lipocortin 1 activation and inhibition of arachidonic acid release (Croxtall et al., 2000).”
Backgroundvan Rossum, E. F. C., Koper, J. W., Huizenga, N. A. T. M., Uitterlinden, A. G., Janssen, J. A. M. J. L., Brinkmann, A. O., Grobbee, D. E., de Jong, F. H., van Duyn, C. M., Pols, H. A. P., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3128 · Cited by 329
Drouin, J., Trifiro, M. A., Plante, R. K., Nemer, M., Eriksson, P., & Wrange, Ö. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5305-5314.1989 · Cited by 283
Reynolds, P. D., Ruan, Y., Smith, D. F., & Scammell, J. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5429 · Cited by 184
Human Glucocorticoid Receptor β Binds RU-486 and Is TranscriptionallyActive
Lewis-Tuffin, L. J., Jewell, C. M., Bienstock, R. J., Collins, J. B., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01439-06 · Cited by 175 · cited 1×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript demonstrated that GRβ regulates gene expression even in the absence of GRα and interacts with the GRα antagonist/partial agonist RU-486, which diminishes its transcriptional capacity (Lewis-Tuffin et al., 2007).”
BackgroundSelective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor
Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00253-07 · Cited by 160
Self-citationRivers, C., Levy, A., Hancock, J., Lightman, S., & Norman, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6235 · Cited by 141
Rižner, T. L., Lin, H. K., Peehl, D. M., Steckelbroeck, S., Bauman, D. R., & Penning, T. M. (2003) · Endocrinology · doi:10.1210/en.2002-0032 · Cited by 132 · cited 1×
“…et al., 1993; Wilson et al., 1994; Yeh et al., 1996; Nelson et al., 1999; Stewart et al., 1999; Flouriot et al., 2000; Quinkler et al., 2003; Rizner et al., 2003; Kobayashi et al., 2004; Pascual-Le Tallec et al., 2004; Lu et al., 2005; Pascual-Le Tallec et al., 2005; Chen et al., 2006;…”
de Lange, P., Segeren, C. M., Koper, J. W., Wiemer, E., Sonneveld, P., Brinkmann, A. O., White, A., Brogan, I. J., de Jong, F. H., & Lamberts, S. W. J. (2010) · Cancer Research · doi:10.1158/0008-5472.3937.61.10 · Cited by 121 · cited 3×
“Studies from a number of laboratories have revealed a correlation between elevated levels of GR-P or GR-A and glucocorticoid resistance in myeloma and leukemia (Moalli et al., 1993; Krett et al., 1995; de Lange et al., 2001).”
BackgroundDifferential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes
Blind, R. D., & Garabedian, M. J. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.01.002 · Cited by 120
Clinical aspects of glucocorticoid sensitivity
Lamberts, S. W. J., Huizenga, A. T. M., de Lange, P., de Jong, F. H., & Koper, J. W. (1996) · Steroids · doi:10.1016/0039-128x(96)00005-0 · Cited by 99
Beger, C., Gerdes, K., Lauten, M., Tissing, W. J. E., Fernandez‐Munoz, I., Schrappe, M., & Welte, K. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04426.x · Cited by 91
Westberry, J. M., Sadosky, P. W., Hubler, T. R., Gross, K. L., & Scammell, J. G. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.03.004 · Cited by 91 · cited 2×
“Furthermore, FKBP51 overexpression inhibits hormone-induced GR transactivation in mammalian cells (Denny et al., 2000; Scammell et al., 2001; Westberry et al., 2006), and co-expression of FKBP52 blocks the inhibitory effect of FKBP51 (Denny et al., 2005; Wochnik et al., 2005).”
BackgroundKelly, A., Bowen, H., Jee, Y.-K., Mahfiche, N., Soh, C., Lee, T., Hawrylowicz, C., & Lavender, P. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.010 · Cited by 83 · cited 1×
“Furthermore, in a manner similar to GRα, GRβ represses basal activity of the interleukin 5 (IL-5) and IL-13 cytokine promoters through recruitment of histone deacetylase 1 (Kelly et al., 2008).”
BackgroundAssociation of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant
Lin, R. C. Y., Wang, X. L., Dalziel, B., Caterson, I. D., & Morris, B. J. (2003) · Obesity Research · doi:10.1038/oby.2003.111 · Cited by 83 · cited 1×
“…in the GR gene, Bcl I and N363S, are associated with generalized increases in glucocorticoid sensitivity (Huizenga et al., 1998; van Rossum et al., 2003; Russcher et al., 2005a) and metabolic disorders (Buemann et al., 1997; Dobson et al., 2001; Di Blasio et al., 2003; Lin et al., 2003).”
BackgroundJewell, C. M., & Cidlowski, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0642 · Cited by 60
Self-citation
Cited by
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 495
Glucocorticoid‐induced leucine zipper (GILZ): a new important mediator of glucocorticoid action
Ayroldi, E., & Riccardi, C. (2009) · The FASEB Journal · doi:10.1096/fj.09-134684 · Cited by 338
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Beck, I. M. E., Vanden Berghe, W., Vermeulen, L., Yamamoto, K. R., Haegeman, G., & De Bosscher, K. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0013 · Cited by 298
Social stress and asthma: The role of corticosteroid insensitivity
Haczku, A., & Panettieri, R. A. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.005 · Cited by 128
Metadata
- Authors
- Gross, K. L., Lu, N. Z., & Cidlowski, J. A.
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 300
- Issue
- 1-2
- Pages
- 7-16
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W1967795360
- Cited by
- 180
- References
- 28
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.